Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001179110-15-014694)

Filing Details

Accession Number:: 0001179110-15-014694
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2015-11-10 16:04:36
Reporting Period:: 2015-11-10

Filing Date:: 2015-11-10
Accepted Time:: 2015-11-10 16:04:36
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1140098	Ocata Therapeutics Inc.	OCAT	Pharmaceutical Preparations (2834)	870656515

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1317093	Robert Lanza	33 Locke Dr. C/O Ocata Therapeutics, Inc. Marlborough MA 01752	Chief Scientific Officer	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2015-11-10	15,000	$8.25	216,509	No	4	S	Direct
Common Stock	Disposition	2015-11-10	10,000	$8.36	206,509	No	4	S	Direct
Common Stock	Disposition	2015-11-10	10,000	$8.36	196,509	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct

Footnotes

Shares sold pursuant to a 10b5-1 Plan.